Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BlueCross BlueShield Assessment Okays Combined TMR/CABG Procedure

This article was originally published in The Gray Sheet

Executive Summary

Transmyocardial revascularization (TMR) performed in conjunction with coronary artery bypass graft surgery on certain patients meet BlueCross BlueShield Association Technology Evaluation Center assessment criteria, according to an assessment summary.
Advertisement

Related Content

TMR Predominantly Used Off Label With CABG, FDA-Backed Study Shows
TMR Predominantly Used Off Label With CABG, FDA-Backed Study Shows
Eclipse Eying Profitability As Medicare TMR Reimbursement Comes On Line
Added Medicare coverage
Added Medicare coverage
Advertisement
UsernamePublicRestriction

Register

MT014851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel